Startup · $18.8m raised
Developing advanced gene therapies for ALS; spun out of Macquarie University.
Sydney, NSW
Every investor coverage indicates participated in a round Celosia Therapeutics raised.
| Investor | Rounds | Invested |
|---|---|---|
| Iomar Barrett | Series A | - |
| Uniseed | Series A | - |
| UniSuper | Series A | - |
| Macquarie University | Seed | - |
Companies Celosia Therapeutics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Brenton Hamdorf | CEO | Startup Daily |
| Dr Kathryn Sunn | CEO | Startup Daily, SmartCompany |
| Prof Lars Ittner | Chief Medical Officer | Startup Daily, SmartCompany |
| Yazi Ke | Chief Operating Officer | SmartCompany |
Stories naming Celosia Therapeutics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
UniSuper adds a further $25 million to its backing of Uniseed, reaching $100 million in total support for the university research commercialisation fund; past cheques to quantum and biotech startups are recapped.
Weekly funding roundup covering eight local companies that together banked $80m, topped by twin $17m Series Bs at Safewill and Fresho, plus Celosia's $16.75m Series A and five smaller rounds.
Also Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·LaunchVic
Weekly roundup reporting nine Australian startups that together secured roughly $104 million across sports tech, semiconductors, regtech, legal automation, SaaS, edtech, agtech and biotech, with Vald's $36 million the largest.
Also Techboard
Macquarie University has spun out gene therapy biotech Celosia Therapeutics with $2 million in Seed funding to develop treatments for neurodegenerative diseases, starting with motor neurone disease.